Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7280 p841
20/27 December 2003

This page
Reprint
Photocopy

   

PDF* 75K

Letters

  Modernisation
  MHRA leaflet
  Aqueous cream
  CPD
  Ramipril
  Community pharmacy
  Fellowships
  Top-up fees
  Product names


Letters to the Editor

Ramipril

Why can’t we take the responsibility?

From Mr M. Cottingham, MRPharmS

I would be interested to know if any doctor had not given their consent for Tritace (ramipril) tablets to be dispensed on prescriptions written for Tritace capsules. Why as the “health expert in the High Street” can I not take that responsibility?

How can we be taken seriously as a profession if we must bother the prescriber on what is essentially a technicality?

Mike Cottingham
Grimsby, South Humberside

Send your letter to The Editor

Previous Topic (CPD)
Next Topic (Community pharmacy)

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal